We describe a case of Guillain-Barre syndrome (GBS) in a patient with non-H
odgkin's lymphoma (NHL). A 21-year-old woman with a newly diagnosed stage I
V high-grade lymphoma (precursor T-cell NHL according to the R.E.A.L. Class
ification) developed flaccid quadriparesis and bilateral facial diplegia af
ter three weeks of treatment with vincristine, daunorubicin, L-asparaginase
and prednisolone. The clinical course and neurological examination were co
nsistent with GBS. Despite treatment with intravenous immunoglobulins her n
eurological symptoms progressed. Plasmapheresis was therefore initiated fol
lowed by intravenous immunoglobulins. After partial remission of neurologic
symptoms, induction chemotherapy with cyclophosphamide and cytarabine was
continued without any further complication. Three months later, the lymphom
a was in complete remission. GBS has been described in Hodgkin's disease an
d after bone marrow transplantation but is rare in NHL. In patients with NH
L who develop neurological symptoms, drug toxicity and nervous system infil
tration are the leading cause of neuropathology, but GBS should be consider
ed in the differential diagnosis.